Serological Markers and Inflammatory Bowel Disease - Badr, Abeer;Saad El-Din, Abd El-Hakim;Al Ansary, Mervat
46,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
23 °P sammeln
  • Broschiertes Buch

The incidence of Crohn's disease (CD) and ulcerative colitis (UC) is increasing, but differentiating between them is often difficult. Anti- Saccharomyces cerevisiae mannan antibodies (ASCA), perinuclear antineutrophil cytoplasmic antibodies (pANCA), pancreatic (PAB) and goblet cell autoantibodies (GAB) are serological markers associated with inflammatory bowel disease (IBD). The clinical significance and diagnostic value of these markers are not well defined in different populations.Determining the prevalence of these serological markers in Egyptian population with IBD and assessing the value…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
The incidence of Crohn's disease (CD) and ulcerative colitis (UC) is increasing, but differentiating between them is often difficult. Anti- Saccharomyces cerevisiae mannan antibodies (ASCA), perinuclear antineutrophil cytoplasmic antibodies (pANCA), pancreatic (PAB) and goblet cell autoantibodies (GAB) are serological markers associated with inflammatory bowel disease (IBD). The clinical significance and diagnostic value of these markers are not well defined in different populations.Determining the prevalence of these serological markers in Egyptian population with IBD and assessing the value of pANCA and ASCA as a diagnostic marker in the differentiation between CD and UC is a critical issue. In addition, the combination of these antibodies with PAB and GAB may improve differentiation between IBD subtypes.
Autorenporträt
Dr. Abeer Mahmoud Badr, Prof. Dr. Somaya El Deeb, Dr. Dalia Yehya Kadry (authors of Cairo University), one of our research field is to assess the importance of some markers as possible prognostic markers in various hematological malignancies.